Thomas Spitznagel - Feb 8, 2024 Form 4 Insider Report for MACROGENICS INC (MGNX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Employee Stock Option (right to buy)	Award	$0	+71K		$0.00	71K	Feb 8, 2024	Common Stock	71K	$18.30	Direct	F1
transaction	MGNX	Restricted Stock Unit	Award	$0	+27K		$0.00	27K	Feb 8, 2024	Common Stock	27K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
F2	Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
F3	The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.